Basel, Switzerland

Patrick Di Giorgio

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 6.2

ph-index = 4

Forward Citations = 61(Granted Patents)


Location History:

  • Riehen, CH (2017 - 2020)
  • Basel, CH (2020 - 2023)

Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Patrick Di Giorgio

Introduction

Patrick Di Giorgio is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds and therapeutic methods. With a total of 12 patents to his name, Di Giorgio's work has had a considerable impact on medical research and drug development.

Latest Patents

Among his latest patents, Di Giorgio has developed peptide macrocycles that serve as potential therapeutic agents. One of his notable inventions includes compounds of formula (I) designed to inhibit ATX. This invention provides novel compounds characterized by a general formula (I), where specific variables are defined, along with compositions that include these compounds and methods for their application.

Career Highlights

Throughout his career, Patrick Di Giorgio has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to contribute to groundbreaking research and development projects.

Collaborations

Di Giorgio has collaborated with esteemed colleagues such as Patrizio Mattei and Daniel Hunziker. These partnerships have fostered innovation and have been instrumental in advancing their shared research goals.

Conclusion

Patrick Di Giorgio's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to influence the development of new therapeutic agents and methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…